scholarly journals Urinary proteomics combined with home blood pressure telemonitoring for health care reform trial: rational and protocol

2021 ◽  
pp. 1-13
Author(s):  
Lutgarde Thijs ◽  
Kei Asayama ◽  
Gladys E. Maestre ◽  
Tine W. Hansen ◽  
Luk Buyse ◽  
...  
2021 ◽  
Vol 39 (Supplement 1) ◽  
pp. e126
Author(s):  
Bruna Gopp Botelho ◽  
Daniella Gomes Barbalho ◽  
Vinicius Leiria Teixeira Louzada ◽  
Rafael Bellotti Azevedo ◽  
Fernando Bizzo Sampaio ◽  
...  

2009 ◽  
Vol 15 (6) ◽  
pp. 281-285 ◽  
Author(s):  
Felicia McCant ◽  
Gwendolyn McKoy ◽  
Janet Grubber ◽  
Maren K Olsen ◽  
Eugene Oddone ◽  
...  

We examined the feasibility of using home blood pressure (BP) telemonitoring devices for managing patients with poor BP control. We enrolled 591 subjects with a diagnosis of hypertension. Patients were randomized to usual care ( n = 147) or to the intervention arm ( n = 441). Those in the intervention arm were issued with a home BP telemonitoring device. The device transmitted BP readings automatically via the home telephone line. Technical alerts were generated if patients did not transmit their BP readings according to the protocol. During the first six months, 693 technical alerts were generated by 267 patients. About half of these patients (112) generated more than two technical alerts. Resolution of the alerts showed that 61% were caused by patient non-adherence. Patients who generated >2 technical alerts were younger (61 vs. 64 years; P = 0.001) and were more likely to be non-Caucasian (64% vs. 47%, P = 0.002) than those generating 2 or fewer alerts. Despite the potential for improving health care using home BP telemonitoring, certain patients will require more support to use the equipment successfully.


2021 ◽  
pp. 1357633X2110317
Author(s):  
Valerie HY Teo ◽  
Sok Huang Teo ◽  
Sarah M Burkill ◽  
Yi Wang ◽  
Evelyn AL Chew ◽  
...  

Introduction Technology to enhance hypertension management is increasingly used in primary care; however, it has not been evaluated in an Asian primary care setting. We aimed to understand the clinical impact and cost-effectiveness of a technology-enabled home blood pressure monitor when deployed in primary care, and patients’ perspectives about the technology. Methods A quasi-experimental cohort study was conducted in a polyclinic in Singapore. In total, 120 patients with hypertension were assigned to the telemonitoring intervention group. Patients received a home blood pressure device connected to the clinical care team's dashboard through a mobile gateway. Tele-consultations and nurse-led tele-support were carried out using established clinical protocols. In total, 120 patients assigned to the control group continued to receive usual care in the polyclinic. Clinical outcomes, cost-effectiveness, and patient satisfaction were measured 6 months after recruitment. Results In total, 217 patients completed 6 months of follow-up. Telemonitoring intervention patients had significantly increased odds of having controlled blood pressure by a factor of 2.69 ( p = 0.01), with the greatest improvement in those whose blood pressure was uncontrolled at baseline ( p < 0.05). The incremental cost-effectiveness ratios for all patients was S$23,935.14/quality-adjusted life year (<1 gross domestic product per capita), which was very cost-effective based on World Health Organization cost-effectiveness thresholds. There was greater satisfaction in telemonitoring intervention group relating to the convenience of recording and sharing blood pressure measurements with the health care team, consultation advice received, understanding by the health care team of their condition, and were more motivated to monitor their blood pressure. Discussion Telemonitoring with tele-consultation improved blood pressure control and was more cost-effective than usual care. Patients receiving telemonitoring intervention were also more motivated and satisfied with their care.


Sign in / Sign up

Export Citation Format

Share Document